Skip to main content

Table 1 qRT-PCR retinal gene expression results in xlpra2, rcd1, and erd mutants compared to normal retinas

From: Photoreceptor proliferation and dysregulation of cell cycle genes in early onset inherited retinal degenerations

 

Ages

Gene

3 wks

5 wks

7 wks

16 wks

Cell cycle: cyclins

  

CCNA1

n.s

n.s

n.s

+4.4x in rcd1

+2.2x in xlpra2

+3.0x in erd (11.9–14.1 w)

CCNA2

n.s

n.s

+2.0x in rcd1

n.s

+2.2x in xlpra2

+2.2x in erd (6.4 w)

+3.2x in erd (8.3–9.9 w)

CCNB1

n.s

n.s

n.s

+3.3x in rcd1

+2.8x in xlpra2

CCND1

n.s

n.s

n.s

+2.4x in rcd1

+2.7x in xlpra2

CCND3

n.s

n.s

n.s

+2.8x in rcd1

CCNE1

n.s

+2.4x in rcd1

+2.7x in rcd1

+5.5x in rcd1

+4.1x in xlpra2

+5.1x in xlpra2

+2.8x in erd (6.4 w)

+10x in erd (11.9–14.1 w)

+5.7x in erd (8.3–9.9 w)

Cell cycle: cyclin-dependent kinases

  

CDK1

n.s

−2.1x in rcd1

−13.3x in rcd1

−2.2x in rcd1

−10.2x in xlpra2

−3.4x in xlpra2

−8.4x in erd (6.4 w)

−6.0x in erd (11.9–14.1 w)

−6.9x in erd (8.3–9.9 w)

CDK2

+2.7x in rcd1

n.s

n.s

+3.4x in rcd1

CDK4

+2.2x in rcd1

n.s

n.s

+2.4x in rcd1

CDK6

+3.6x in rcd1

n.s

n.s

+2.9x in rcd1

+2.5x in xlpra2

+2.1x in xlpra2

Cell division cycle phosphatases

  

CDC25A

n.s

n.s

n.s

n.s

CDC25B

n.s

n.s

n.s

n.s

CDC25C

n.s

n.s

n.s

+2.1x in rcd1

+2.7x in xlpra2

Cyclin-dependent kinase inhibitors

  

CDKN1A

n.s

n.s

n.s

n.s

CDKN1B

n.s

n.s

n.s

n.s

CDKN2A

−3.8x in rcd1

n.s

+3.0x in erd (8.3–9.9 w)

n.s

Cell cycle transcription regulators

  

BMI1

n.s

n.s

n.s

n.s

E2F1

+2.0x in rcd1

n.s

n.s

+6.2x in rcd1

+2.6x in xlpra2

+3.7x in xlpra2

RB1

+2.1x in rcd1

n.s

n.s

n.s

+5.5x in xlpra2

Hippo signaling/NDR kinases

  

LATS1

n.s

n.s

n.s

+2.6x in erd (11.9–14.1 w)

LATS2

n.s

n.s

n.s

n.s

MOB1A

n.s

n.s

n.s

+2.5x in erd (11.9–14.1 w)

NDR1

n.s

n.s

n.s

+2.1x in erd (11.9–14.1 w)

STK38L (NDR2) (exons 4–5)

n.s

n.s

No expression in erd

No expression in erd

STK38L (NDR2) (exons 6–7)

n.s

n.s

n.s

n.s

Eye development regulation via proliferation/apoptosis

 

PAX6

n.s

n.s

−2.5x in erd (6.4 w)

+2.2x in rcd1

PCNA

n.s

n.s

n.s

n.s

PR function

   

GRK1

n.s

−2.0x in rcd1

−3.9x in rcd1

−3.3x in rcd1

−2.3x in xlpra2

RBP3

n.s

n.s

n.s

n.s

RCVRN

n.s

n.s

−2.6x in rcd1

−2.4x in rcd1

−2.2x in xlpra2

−2.0x in erd (11.9–14.1 w)

PR development/structure

   

CRB1

n.s

n.s

n.s

n.s

NRL

n.s

−2.3x in rcd1

−2.0x in rcd1

−3.0x in rcd1

−3.2x in erd (6.4 w)

−2.0x in xlpra2

−3.7x in erd (8.3-9.9 w)

−5.8x in erd (11.9–14.1 w)

NR2E3

n.s

−2.0x in rcd1

−2.8x in erd (6.4 w)

n.s

RDS

n.s

−2.5x in rcd1

−2.0x in rcd1

−3.0x in rcd1

  1. Statistically significant (p < 0.05 and FC > +/−2) differences in retinal gene expression are reported in comparison to normals at different ages (rcd1 and xlpra2: 3, 5, 7, 16 wks; erd: 6.4, 8.3–9.9, 11.9–14.1 wks). The examined genes are reported in alphabetical order within functional groups. The complete list of genes tested is available as Additional file 5. n.s = not statistically significant; + = up-regulated and - = down-regulated compared to normal